Women with triple negative breast cancer will gain access to pembrolizumab after deal with its manufacturer
Women with a particularly aggressive form of breast cancer have been given access to a “potentially life-saving” drug after NHS bosses struck a deal with its manufacturer.
Up to 1,600 women a year will be able to get pembrolizumab, which has the potential to leave some of those who take it completely free of cancer, NHS England said.
Women with triple negative breast cancer will gain access to pembrolizumab after deal with its manufacturerWomen with a particularly aggressive form of breast cancer have been given access to a “potentially life-saving” drug after NHS bosses struck a deal with its manufacturer.Up to 1,600 women a year will be able to get pembrolizumab, which has the potential to leave some of those who take it completely free of cancer, NHS England said. Continue reading…
